Electronic Product Information Leaflet (ePIL): Opportunities, Challenges, and Future Directions

The purpose of EPILs, the electronic version of the leaflets placed in pharmaceutical packaging, is to enhance patient understanding and information access. ePILs present a chance to optimize patient safety, engagement, and adherence as digital health continues to grow. The evidence that currently exists on patient preference, eHealth literacy, and ePIL adoption is examined in the following paper together with the positive aspects, difficulties, and potential implementation strategies. A qualitative examination of research from various nations shows that while ePILs improve accessibility and user satisfaction, issues with digital literacy, user interface, and trust still exist. There is consideration of the implications both for implementation in healthcare systems and future research.

Electronic product information leaflets, or ePILs, give patients a better understanding of their medications and boost their confidence when taking them. However, problems like workflow integration and low digital literacy can limit their efficacy. Future studies should concentrate on vulnerable populations, long-term effects, and explicit regulations. When used appropriately, ePILs can enhance health literacy, safety, and adherence.